GOSS — Gossamer Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Gossamer Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	513	325	256	296	295
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	5.34
Prepaid Expenses
Total Other Current Assets
Total Current Assets	522	332	262	307	310
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.1	10.8	9.89	4.78	5.12
Other Long Term Assets
Total Assets	539	344	272	312	315
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	38.6	39.9	49.2	51.6	45
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	219	222	260	249	286
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	321	121	12.1	62.8	29.5
Total Liabilities & Shareholders' Equity	539	344	272	312	315
Total Common Shares Outstanding